Risk factors for allergic rhinitis in preschool children: a meta-analysis and systematic review

Nannan Si1,2,3, Wei Chang2, Fengli Cheng1,3

  • 1Department of Otolaryngology Head and Neck Surgery, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030001, China.

BMC Pediatrics
|August 7, 2025
PubMed

Insights

Parental allergies, male sex, and damp homes increase the risk of allergic rhinitis (AR) in young children. Conversely, having pets at home may protect against AR development.

Area of Science:

  • Pediatrics
  • Allergology
  • Environmental Health

Background:

  • Allergic rhinitis (AR) significantly impacts preschool children's quality of life.
  • Identifying AR risk factors is crucial for early diagnosis and prevention.

Purpose of the Study:

  • To conduct a meta-analysis identifying and summarizing risk factors for allergic rhinitis in preschool children.

Main Methods:

  • Systematic literature search of major databases up to January 2025.
  • Inclusion of 10 cohort studies with 94,774 preschool children.
  • Random-effects model to calculate combined odds ratios (OR) and 95% confidence intervals (CI).

Main Results:

  • Parental allergic rhinitis (OR=2.4), eczema (OR=1.72), and asthma (OR=2.45) were associated with increased AR risk.
  • Male sex (OR=1.54), caesarean birth (OR=1.32), and home dampness (OR=1.24) also increased AR odds.
  • Presence of pets at home showed a protective effect, reducing AR risk (OR=0.57).

Conclusions:

  • Parental allergy history, male gender, caesarean birth, and damp environments are potential risk factors for childhood AR.
  • Pet ownership may offer a protective role against developing allergic rhinitis.
  • Findings highlight the interplay of genetic and environmental influences on pediatric allergic rhinitis.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Allergic Reactions02:06

Allergic Reactions

Overview
28.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
593
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
293
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
461